243 related articles for article (PubMed ID: 17952078)
1. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
Horng T; Bezbradica JS; Medzhitov R
Nat Immunol; 2007 Dec; 8(12):1345-52. PubMed ID: 17952078
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell signaling pathways.
Vivier E; Nunès JA; Vély F
Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell receptor signaling pathway.
Vély F; Vivier E
Sci STKE; 2005 Jul; 2005(292):cm6. PubMed ID: 16014603
[TBL] [Abstract][Full Text] [Related]
5. The NKG2D receptor: sensing stressed cells.
López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
[TBL] [Abstract][Full Text] [Related]
6. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells.
Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP
Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026
[TBL] [Abstract][Full Text] [Related]
7. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.
Upshaw JL; Leibson PJ
Semin Immunol; 2006 Jun; 18(3):167-75. PubMed ID: 16723257
[TBL] [Abstract][Full Text] [Related]
8. NKG2D ligands: key targets of the immune response.
González S; López-Soto A; Suarez-Alvarez B; López-Vázquez A; López-Larrea C
Trends Immunol; 2008 Aug; 29(8):397-403. PubMed ID: 18602338
[TBL] [Abstract][Full Text] [Related]
9. NKG2D ligands in tumor immunity.
Nausch N; Cerwenka A
Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
[TBL] [Abstract][Full Text] [Related]
10. Versatile signaling through NKG2D.
Long EO
Nat Immunol; 2002 Dec; 3(12):1119-20. PubMed ID: 12447364
[No Abstract] [Full Text] [Related]
11. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
Diefenbach A; Tomasello E; Lucas M; Jamieson AM; Hsia JK; Vivier E; Raulet DH
Nat Immunol; 2002 Dec; 3(12):1142-9. PubMed ID: 12426565
[TBL] [Abstract][Full Text] [Related]
12. NKG2D and cytotoxic effector function in tumor immune surveillance.
Hayakawa Y; Smyth MJ
Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
[TBL] [Abstract][Full Text] [Related]
13. NK cells and cancer immunosurveillance.
Waldhauer I; Steinle A
Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell receptor signaling pathway in mammals.
Vély F; Vivier E
Sci STKE; 2005 Jul; 2005(292):cm7. PubMed ID: 16014604
[TBL] [Abstract][Full Text] [Related]
16. The role of the NKG2D receptor for tumor immunity.
Coudert JD; Held W
Semin Cancer Biol; 2006 Oct; 16(5):333-43. PubMed ID: 16914326
[TBL] [Abstract][Full Text] [Related]
17. NKG2D function protects the host from tumor initiation.
Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
[TBL] [Abstract][Full Text] [Related]
18. Pathways participating in activation of mouse uterine natural killer cells during pregnancy.
Xie X; He H; Colonna M; Seya T; Takai T; Croy BA
Biol Reprod; 2005 Sep; 73(3):510-8. PubMed ID: 15878887
[TBL] [Abstract][Full Text] [Related]
19. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
[TBL] [Abstract][Full Text] [Related]
20. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]